Department of Neurology, Molde Hospital, Molde, Norway.
Neuroepidemiology. 2011;37(1):58-63. doi: 10.1159/000329523. Epub 2011 Aug 22.
To determine the annual incidence rate and clinical features of amyotrophic lateral sclerosis (ALS) in Møre and Romsdal County, Norway, in the 20-year period from 1988 to 2007.
We recruited ALS patients retrospectively from the patient database of the two neurological departments in Møre and Romsdal County, Norway. The patients were identified by use of the international classification code for diseases. We recorded gender, age, municipality, symptoms, clinical signs, time from onset to diagnosis and death.
105 patients met the inclusion criteria. The crude annual incidence was 2.17 per 100,000 for the period 1988-2007. Gender-specific incidence for men was 2.32 per 100,000, and for women 2.03 per 100,000. Mean age at symptom onset was 66.8 ± 10.5 years. Mean interval from onset of symptoms to diagnosis was 13.5 ± 11.0 months, and mean survival time from diagnosis was 18.0 ± 22.0 months. Prevalence rate estimated on December 31, 2007 was 4.06 per 100,000.
The present study shows an annual incidence of ALS of similar magnitude to the previous studies from the Nordic countries during the past years. The short survival time corroborates prior studies, and is stable throughout the two studied decades.
确定挪威摩尔达伦郡(Møre and Romsdal County)在 1988 年至 2007 年的 20 年间,肌萎缩侧索硬化症(ALS)的年发病率和临床特征。
我们通过挪威摩尔达伦郡的两个神经科的患者数据库,回顾性地招募 ALS 患者。患者通过国际疾病分类代码确定。我们记录了性别、年龄、市、症状、临床特征、从发病到诊断和死亡的时间。
105 名患者符合纳入标准。1988-2007 年期间,粗发病率为每 10 万人 2.17 例。男性的性别特异性发病率为每 10 万人 2.32 例,女性为每 10 万人 2.03 例。症状发作时的平均年龄为 66.8 ± 10.5 岁。从症状发作到诊断的平均间隔为 13.5 ± 11.0 个月,从诊断到死亡的平均生存时间为 18.0 ± 22.0 个月。2007 年 12 月 31 日的患病率估计为 4.06/10 万。
本研究显示,ALS 的年发病率与过去几年北欧国家的先前研究相似。较短的生存时间证实了之前的研究,并在两个研究十年中保持稳定。